Zobrazeno 1 - 10
of 11
pro vyhledávání: '"H. C. M. Haanen"'
Publikováno v:
Clinical Rheumatology. 26:529-532
Temporal arteritis (TA) may offer major complications, whilst high dosage of prednisone may result in serious side effects. We tried to identify a subgroup of TA, which can be treated with a lower dosage of prednisone. Retrospectively, clinical and l
Autor:
H. C. M. Haanen, Y Schenk, Aike A. Kruize, C van Booma-Frankfort, D. M. Hofman, H L M Brus, E. J. Ter Borg, A A M Blaauw, M. J. Van Der Veen, J. W. J. Bijlsma, G A van Albada-Kuipers, A H M Heurkens, C. H. M. Van Jaarsveld, J. W. G. Jacobs
Publikováno v:
Annals of the Rheumatic Diseases. 59:468-477
OBJECTIVES To compare three therapeutic strategies using slow acting antirheumatic drugs (SAARDs) in early rheumatoid arthritis (RA), for their disease modifying properties, toxicity, and lag time until treatment effect. METHODS Patients with recent
Autor:
H. C. M. Haanen, J. W. J. Bijlsma, A. J. P. Schrijvers, A H M Heurkens, C. H. M. Van Jaarsveld, J. W. G. Jacobs
Publikováno v:
Rheumatology. 37:837-847
The objective was to estimate the annual direct disease-related cost of rheumatoid arthritis (RA) during the first 6 yr and to determine which socio-demographic and clinical characteristics relate to these costs. The study population consisted of 424
Autor:
A. Croone, H. H. M. L. Houben, J. W. J. Bijlsma, W.F. Lems, W. G. Jacobs, H. C. M. Haanen, M. I. Gerrits, H. J. M. Van Rijn
Publikováno v:
Osteoporosis international, 7(6), 575-582. Springer London
To investigate whether sodium fluoride (NaF) is able to prevent bone loss in patients treated with corticosteroids (Cs), we performed a randomized double-masked, placebo-controlled trial with 44 Cs-treated patients without established osteoporosis, d
Autor:
F. E. E. Vermeulen, H. C. M. Haanen, W. J. Morshuis, J. R. J. Elbers, C. J. A. M. Zeebregts, J. M. P. G. Ernst
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 45:97-99
Aortitis with involvement of the aortic valve is rarely associated with vasculitis syndromes. We present a patient with antibodies to a neutrophil cytoplasmic antigen-associated (ANCA) vasculitis with renal failure who developed aortic incompetence a
Autor:
E J, ter Borg, H C M, Haanen, F J L M, Haas, J H G M, Bistervels, F W, Huisman, J A, Kerckhaert, C G M, Kallenberg
Publikováno v:
The Netherlands journal of medicine. 60(10)
Up to now no satisfying systemic treatment is available for patients with primary Sjögren's syndrome.In a prospective, open study we investigated the effect of D-penicillamine (first three months 250 mg/day, next three months 500 mg/day) on clinical
Autor:
H. C. M. Haanen, K. H. Njoo
Publikováno v:
Reumatologie ISBN: 9789031327737
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10186382e78ceb8306bef985ffb49ae4
https://doi.org/10.1007/978-90-368-0475-2_5
https://doi.org/10.1007/978-90-368-0475-2_5
Publikováno v:
Clinical rheumatology. 18(1)
We investigated, in retrospect, if there were differences in the frequency and types of abdominal surgery between newly diagnosed female fibromyalgia (n = 80) and rheumatoid arthritis (n = 47) patients performed before the formal diagnosis. There was
Autor:
M. I. Gerrits, H. H. M. L. Houben, J. W. G. Jacobs, H. C. M. Haanen, G. J. M. Van Veen, J. W. J. Bijlsma, W.F. Lems, H. J. M. Van Rijn
Publikováno v:
Annals of the rheumatic diseases, 56(6), 357-363. BMJ Publishing Group
OBJECTIVE—To investigate whether administration of sodium fluoride (NaF) in addition to cyclical etidronate has a positive effect on bone mineral density (BMD) in patients with established osteoporosis during continued treatment with corticosteroid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7865b3808aa89f9507fef89db2835e45
https://pure.amc.nl/en/publications/is-addition-of-sodium-fluoride-to-cyclical-etidronate-beneficial-in-the-treatment-of-corticosteroid-induced-osteoporosis(8c0233ee-9025-4017-a7ea-e3239744de3e).html
https://pure.amc.nl/en/publications/is-addition-of-sodium-fluoride-to-cyclical-etidronate-beneficial-in-the-treatment-of-corticosteroid-induced-osteoporosis(8c0233ee-9025-4017-a7ea-e3239744de3e).html
Autor:
E J ter Borg, H. J. Dinant, G A van Albada-Kuipers, M. J. Van Der Veen, J. W. G. Jacobs, Aike A. Kruize, H. C. M. Haanen, D. M. Hofman, Y Schenk, A. van der Heide, H L M Brus, C van Booma-Frankfort, J. W. J. Bijlsma, A H M Heurkens
Publikováno v:
Annals of internal medicine. 124(8)
Objective : To compare two therapeutic strategies for patients with recent-onset rheumatoid arthritis. Design : Open, randomized clinical trial. Setting : Outpatient clinics of six clinical centers. Patients : 238 consecutive patients with recently d